Kimura, Hiroshi

Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease

Tooyama, I., Kimura, H., Akiyama, H., & McGeer, P. L. (1990) · Brain Research

Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Cited by 180

Cholinergic projections from the basal forebrain of rat to the amygdala

Nagai, T., Kimura, H., Maeda, T., McGeer, P., Peng, F., & McGeer, E. (1982) · The Journal of Neuroscience

Memory and Neural MechanismsNeuroscience and Neuropharmacology Research

Cited by 140

Dopamine supersensitivity psychosis as a pivotal factor in treatment-resistant schizophrenia

Suzuki, T., Kanahara, N., Yamanaka, H., Takase, M., Kimura, H., Watanabe, H., & Iyo, M. (2015) · Psychiatry Research

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 81

Chronic foot‐shock stress potentiates the influx of bone marrow‐derived microglia into hippocampus

Brevet, M., Kojima, H., Asakawa, A., Atsuchi, K., Ushikai, M., Ataka, K., Inui, A., Kimura, H., Sevestre, H., & Fujimiya, M. (2010) · Journal of Neuroscience Research

Neuroinflammation and Neurodegeneration MechanismsStress Responses and Cortisol

Cited by 62

A prospective comparative study of risperidone long-acting injectable for treatment-resistant schizophrenia with dopamine supersensitivity psychosis

Kimura, H., Kanahara, N., Komatsu, N., Ishige, M., Muneoka, K., Yoshimura, M., Yamanaka, H., Suzuki, T., Komatsu, H., Sasaki, T., et al. (2014) · Schizophrenia Research

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 55

Dopamine supersensitivity psychosis and dopamine partial agonist: A retrospective survey of failure of switching to aripiprazole in schizophrenia

Takase, M., Kanahara, N., Oda, Y., Kimura, H., Watanabe, H., & Iyo, M. (2015) · Journal of Psychopharmacology

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 54

Risperidone long-acting injectable in the treatment of treatment-resistant schizophrenia with dopamine supersensitivity psychosis: Results of a 2-year prospective study, including an additional 1-year follow-up

Kimura, H., Kanahara, N., Sasaki, T., Komatsu, N., Ishige, M., Muneoka, K., Ino, H., Yoshimura, K., Yamanaka, H., Suzuki, T., et al. (2016) · Journal of Psychopharmacology

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 26